NDC 51079-223-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-223
- Requested NDC
- 51079-223-01
- Package NDCs from labels
- 51079-223-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-223-01 | EA - Each | 51079-223 | 9aefb30f-0dec-4fbd-9cdd-648220b9e42a | 1 | 2013-02-13 |
| 51079-223-20 | EA - Each | 51079-223 | d4487152-ade0-4e4d-ba36-8befe2edc35d | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast Sodium | MONTELUKAST SODIUM | Torrent Pharmaceuticals Limited | da038cf6-cfad-43a4-ab8e-d81d028d6087 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | Montelukast Sodium MONTELUKAST SODIUM |
| montelukast sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 1eeb3123-9e93-4681-8096-800a7c7acf8a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| Montelukast Sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals Inc. | 64a3b181-e8d8-4caf-9f1b-e0063d0bd94a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | Montelukast Sodium MONTELUKAST SODIUM |
| Montelukast Sodium | MONTELUKAST SODIUM | Rising Pharma Holdings, Inc. | 49669ac0-0bb5-4576-bed5-9e85e0d76a44 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | Montelukast Sodium MONTELUKAST SODIUM |
| Polyethylene Glycol (3350) | POLYETHYLENE GLYCOL (3350) | Mylan Institutional Inc. | 219bcbc4-b84a-4209-9f34-ef2b0ef0d273 | 2026-04-08 | Warnings | Mylan Institutional Inc. |
| montelukast sodium | MONTELUKAST SODIUM | A-S Medication Solutions | 7ff11e37-9ea5-40b6-96f7-4caf27cab756 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| montelukast sodium | MONTELUKAST SODIUM | A-S Medication Solutions | 1a312a28-8472-4cab-a7dd-d01cd8b2765a | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| montelukast sodium | MONTELUKAST SODIUM | A-S Medication Solutions | 25b2049d-3a93-4ac3-8de6-14f5d7ce0315 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| montelukast sodium | MONTELUKAST SODIUM | A-S Medication Solutions | 04b3faff-1ea1-4d2a-aa31-9d6e742e1759 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| Chlorthalidone | CHLORTHALIDONE | Mylan Institutional Inc. | 193c85ba-43c2-4be2-82cf-7b394a83390e | 2026-01-20 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| montelukast sodium | MONTELUKAST SODIUM | Preferred Pharmaceuticals, Inc. | 09b0bc9e-3035-45b4-b61b-4aca70848360 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | montelukast sodium MONTELUKAST SODIUM |
| Montelukast Sodium | MONTELUKAST SODIUM | Redpharm Drug | 2fbdf1be-a37f-879b-e063-6394a90aa20d | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | Montelukast Sodium MONTELUKAST SODIUM |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Chartwell RX, LLC | 5cb4298c-10b1-4d6f-95ad-4aad72daf249 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | MONTELUKAST SODIUM MONTELUKAST SODIUM |
| Montelukast Sodium | MONTELUKAST SODIUM | AvKARE | ed2caffa-a75c-1c27-ae30-2d8280eaea7d | 2025-12-16 | Warnings, Adverse reactions | Montelukast Sodium MONTELUKAST SODIUM |
| MONTELUKAST | MONTELUKAST SODIUM | A-S Medication Solutions | da9821f1-536a-416b-9594-210bde0cefaf | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | MONTELUKAST SODIUM |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional Inc. | 08e1bfea-7f3f-42d9-823d-f75080e664ff | 2025-11-12 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Chlordiazepoxide Hydrochloride | CHLORDIAZEPOXIDE HYDROCHLORIDE | Mylan Institutional Inc. | 68c7d8a7-08b3-4a1a-acbd-09bbe67b8d4a | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Clozapine | CLOZAPINE | Mylan Institutional Inc. | d5c8a456-6f3c-4963-b321-4ed746f690e4 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 52fea941-0b47-41c1-b00d-f88150e8ab93 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Divalproex Sodium | DIVALPROEX SODIUM | Mylan Institutional Inc. | b367d81d-4eca-4e28-b490-34be4c003561 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.